IVD Quality Control Market worth $1,158 Million by 2025

-

 

According to research report the global IVD Quality Control Market is projected to reach USD 1,158 million by 2025 from USD 961 million in 2020, at a CAGR of 3.8% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=198032582

The IVD quality control market is primarily driven by increasing demands for laboratory accreditation, as well as the rising number of accredited laboratories and growing adoption of third-party quality controls. However, the lack of regulations for clinical laboratory accreditation in several emerging countries will challenge market growth.

On the basis of type, the quality control products market is segmented into serum/plasma-based controls, whole blood-based controls, urine-based controls, and other controls (controls manufactured from spinal fluid, lipoprotein extracts, and immunoproteins). The serum/plasma-based controls segment is expected to account for the largest market share in 2019. The large share of this segment is mainly attributed to the greater uptake of serum/plasma-based quality controls among laboratories and the widening application areas of these controls for various IVD tests.

Based on applications, the IVD quality control market is segmented into clinical chemistry, immunochemistry, hematology, coagulation & hemostasis, microbiology, molecular diagnostics, and other applications (ESR, urine chemistry, immunology, cardiac assessment, and blood morphology). The molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the rising prevalence of infectious diseases, cancer, and various genetic disorders; the growing demand for blood screening; and the increasing application of molecular diagnostic technologies in pharmacogenetics and point-of-care testing.

The North America is expected to account for the largest share of the global IVD quality control market in 2020, followed by Europe. The large share of the North America can be attributed to the highly developed healthcare system in the US and Canada, and the presence of a large number of leading IVD quality control vendors & national clinical laboratories & hospitals in this region.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=198032582

The prominent players in this IVD Quality Control Market are Bio-Rad Laboratories Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific Inc. (US), Technopath Clinical Diagnostics (Ireland), Bio-Techne Corporation (US), Fortress Diagnostics (UK), SeraCare Life Sciences Inc. (US), SERO AS (Norway), Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), and Abbott Laboratories Inc. (US).

Comments

Post a Comment

Popular posts from this blog

Minimally Invasive Surgical Instruments Market Report, 2026

-
The global minimally invasive surgical instruments market is projected to reach USD 28.9 billion by 2026 from USD 20.2 billion in 2021, at a CAGR of 7.4% during the forecast period. Growth in this market is mainly driven by factors such as the increasing number of surgical procedures worldwide, the advantages of MIS over open surgical techniques, and the increasing adoption of advanced robotics in ASCs. However, the high degree of market consolidation among market players and the requirement of high capital investments are the major factors hampering the growth of this market. Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=682 The key players in this market are Medtronic plc (Ireland), Johnson Johnson (US), Stryker Corporation (US), Abbott Laboratories, Inc. (US), Boston Scientific Corporation (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Smith Nephew plc (UK), Zimmer Biomet Holdings, Inc. (US), Becton, Dickinson and Comp...
Read more

Advancements Fueling Cardiac Monitoring Devices Market Growth

-
The global Cardiac Monitoring and Management Devices Market has been experiencing an upward surge, projected to reach an impressive USD 26.8 billion by 2025 from its valuation of USD 22.1 billion in 2020, with a steady Compound Annual Growth Rate (CAGR) of 4.0% from 2020 to 2025. This exponential growth can be attributed to several key factors that continue to shape and propel this industry forward. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=55 Factors Driving Cardiac Monitoring Devices Market Growth Rising Cardiovascular Disease Prevalence: The prevalence of cardiovascular diseases (CVD) is on the rise globally, driving the demand for advanced cardiac monitoring devices. This trend is a significant catalyst for the market's growth trajectory. Innovative Product Launches: Market players have been proactive in introducing innovative products, leveraging advanced technologies. These advancements include improved algorithms, simplified...
Read more

Antimicrobial Susceptibility Testing Market : Emerging Market Trends, Top Growing Segments and Future Trends

-
Growth in this  antimicrobial susceptibility testing market is primarily driven by the rising incidence of infectious diseases; technological advancements towards the development of rapid AST technologies; increased funding, research grants, and public-private investments; growing government initiatives to detect and control antimicrobial-resistant species; and the emergence of multidrug resistance due to drug abuse. However, the high cost of automated antimicrobial susceptibility testing systems is expected to limit market growth in the coming years. Complex regulatory frameworks that delay the approval of new microbial susceptibility tests are also expected to challenge market growth to a certain extent. According to research report the global antimicrobial susceptibility testing market size is projected to reach USD 4.2 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 5.5% during the forecast period. Download PDF Brochure: https://www.marketsandmarkets.c...
Read more